The Market Stopped Rotating and Started Choosing: Software and Health Care Over the Rate-Sensitive Economy

Market regime

The 10/09 session broke the pattern of the last two weeks. Rather than a rotation (money out of one block and into another), the tape simply bought more: the average US stock gained +0.41% on 2,916 advancers against 1,686 decliners, and the share of names holding their 50-day rose to 30.9%. Yet leadership was narrow at the top — mega-caps returned +0.80% versus 0.00% for the smallest decile — so this was breadth plus concentration, not breadth instead of it. The distinguishing feature is what got bought: Health Care +1.9% and Information Technology +1.2% led, while the rate-sensitive, credit-sensitive, dollar-sensitive end of the market — banks (3.4% above their 50-day), mortgage and office REITs (0%), homebuilders (4.5%) — kept bleeding. This is a market paying for secular growth and duration, and refusing to pay for economic cyclicality.

Mega forces

1. Compute is being re-underwritten, not sold. After the mid-week wobble, software and cyber reasserted leadership: Cybersecurity stocks are up +15.7% over the month with 81% above their 50-day — the highest participation in the entire universe — led by Zscaler +43%, Okta +36%, CrowdStrike +32% and Palo Alto +24% on the month. Enterprise Cloud Applications (+8.4%) and Semiconductor Capital Equipment (+8.3%) sit right behind. The market is distinguishing between AI builders (volatile, legal/export-headline-exposed) and AI landlords — software, security, storage, data-center networking — which monetize adoption regardless of who wins the model race.

2. Health care has quietly turned. Health Care gained +1.9% and is the only cyclical-adjacent block with improving internals. Moderna +14.2% (up 65% in a month), Humana +11.6% after a Medicare Advantage star-rating upgrade restored a bonus-payment tailwind, Illumina +5.1%, and Biopharma Drug Discovery Platforms +4.7% on the day with Life Science Tools +11.4% over the month. Add the pace of consolidation — Viatris/Pacira at a 45% premium, Novartis/Abogen at up to $7.8B — and a sector that spent a year as a funding source is now being accumulated.

3. Capital is being redirected inside communications. SpaceX's ~$8B purchase of Grain Management's 800 MHz spectrum repriced the entire US wireless complex in one session: Verizon -10.1%, AT&T -10.8%, T-Mobile -13.3% — roughly $60B of carrier market value — while the towers they were expected to not need rallied hard (Crown Castle +15.6%, American Tower +9.3%, SBA +7.3%). The insight is not "satellite beats wireless"; it is that a single capital-allocation decision can invalidate a decades-old moat — and the market is now pricing terrestrial-tower demand as more durable, not less.

What's working

Secular software/security, select biotech and life-science tools, and integrated oil (86% of names above their 50-day) are working. Avoid the pure rate-cycle trade: regional banks, mortgage and office REITs, homebuilders, and industrials-ex-construction are all trading at or below their 50-day with -5% to -13% monthly returns. Gold and silver miners (-9.8% 1M) and EV/solar/quantum remain funding sources, not opportunities.

Strategy

With the 10-year at 4.63%, a firm dollar (+3.6% 1M) and the VIX at 14.6, the path of least resistance is quality growth funded by balance-sheet-light cyclicals. Our preference is to own the AI-adoption toll collectors — cybersecurity, cloud infrastructure software, data-center networking — and to add health care selectively where M&A and policy (star ratings, approvals) are turning. Q3 earnings season opens in earnest imminently with 357 names reporting in the next two weeks; with guidance risk elevated, size positions around reported results rather than ahead of them. Keep exposure to the rate-sensitive value complex minimal until the 50-day participation there stops making new lows.